PortfoliosLab logo
CRNC vs. BDSX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CRNC and BDSX is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.2

Performance

CRNC vs. BDSX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cerence Inc. (CRNC) and Biodesix, Inc. (BDSX). The values are adjusted to include any dividend payments, if applicable.

-100.00%-90.00%-80.00%-70.00%-60.00%NovemberDecember2025FebruaryMarchApril
-83.24%
-95.79%
CRNC
BDSX

Key characteristics

Sharpe Ratio

CRNC:

-0.00

BDSX:

-0.81

Sortino Ratio

CRNC:

1.94

BDSX:

-1.17

Omega Ratio

CRNC:

1.22

BDSX:

0.85

Calmar Ratio

CRNC:

-0.01

BDSX:

-0.59

Martin Ratio

CRNC:

-0.01

BDSX:

-1.66

Ulcer Index

CRNC:

57.55%

BDSX:

34.81%

Daily Std Dev

CRNC:

212.80%

BDSX:

71.94%

Max Drawdown

CRNC:

-98.22%

BDSX:

-98.43%

Current Drawdown

CRNC:

-92.72%

BDSX:

-98.27%

Fundamentals

Market Cap

CRNC:

$419.46M

BDSX:

$83.38M

EPS

CRNC:

-$15.27

BDSX:

-$0.33

PS Ratio

CRNC:

1.72

BDSX:

1.17

PB Ratio

CRNC:

3.48

BDSX:

3.77

Total Revenue (TTM)

CRNC:

$176.24M

BDSX:

$56.51M

Gross Profit (TTM)

CRNC:

$118.40M

BDSX:

$44.11M

EBITDA (TTM)

CRNC:

-$377.81M

BDSX:

-$19.45M

Returns By Period

In the year-to-date period, CRNC achieves a 23.69% return, which is significantly higher than BDSX's -64.77% return.


CRNC

YTD

23.69%

1M

22.99%

6M

232.53%

1Y

-0.00%

5Y*

-13.92%

10Y*

N/A

BDSX

YTD

-64.77%

1M

-19.55%

6M

-67.13%

1Y

-56.36%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CRNC vs. BDSX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRNC
The Risk-Adjusted Performance Rank of CRNC is 6464
Overall Rank
The Sharpe Ratio Rank of CRNC is 5252
Sharpe Ratio Rank
The Sortino Ratio Rank of CRNC is 8585
Sortino Ratio Rank
The Omega Ratio Rank of CRNC is 8080
Omega Ratio Rank
The Calmar Ratio Rank of CRNC is 5252
Calmar Ratio Rank
The Martin Ratio Rank of CRNC is 5151
Martin Ratio Rank

BDSX
The Risk-Adjusted Performance Rank of BDSX is 1010
Overall Rank
The Sharpe Ratio Rank of BDSX is 1010
Sharpe Ratio Rank
The Sortino Ratio Rank of BDSX is 1010
Sortino Ratio Rank
The Omega Ratio Rank of BDSX is 1111
Omega Ratio Rank
The Calmar Ratio Rank of BDSX is 1515
Calmar Ratio Rank
The Martin Ratio Rank of BDSX is 44
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CRNC vs. BDSX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Cerence Inc. (CRNC) and Biodesix, Inc. (BDSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for CRNC, currently valued at -0.00, compared to the broader market-2.00-1.000.001.002.003.00
CRNC: -0.00
BDSX: -0.81
The chart of Sortino ratio for CRNC, currently valued at 1.94, compared to the broader market-6.00-4.00-2.000.002.004.00
CRNC: 1.94
BDSX: -1.17
The chart of Omega ratio for CRNC, currently valued at 1.22, compared to the broader market0.501.001.502.00
CRNC: 1.22
BDSX: 0.85
The chart of Calmar ratio for CRNC, currently valued at -0.01, compared to the broader market0.001.002.003.004.005.00
CRNC: -0.01
BDSX: -0.59
The chart of Martin ratio for CRNC, currently valued at -0.01, compared to the broader market-5.000.005.0010.0015.0020.00
CRNC: -0.01
BDSX: -1.66

The current CRNC Sharpe Ratio is -0.00, which is higher than the BDSX Sharpe Ratio of -0.81. The chart below compares the historical Sharpe Ratios of CRNC and BDSX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.80-0.60-0.40-0.200.000.200.40NovemberDecember2025FebruaryMarchApril
-0.00
-0.81
CRNC
BDSX

Dividends

CRNC vs. BDSX - Dividend Comparison

Neither CRNC nor BDSX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

CRNC vs. BDSX - Drawdown Comparison

The maximum CRNC drawdown since its inception was -98.22%, roughly equal to the maximum BDSX drawdown of -98.43%. Use the drawdown chart below to compare losses from any high point for CRNC and BDSX. For additional features, visit the drawdowns tool.


-100.00%-95.00%-90.00%-85.00%NovemberDecember2025FebruaryMarchApril
-92.72%
-98.27%
CRNC
BDSX

Volatility

CRNC vs. BDSX - Volatility Comparison

Cerence Inc. (CRNC) has a higher volatility of 35.73% compared to Biodesix, Inc. (BDSX) at 29.13%. This indicates that CRNC's price experiences larger fluctuations and is considered to be riskier than BDSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


20.00%40.00%60.00%80.00%100.00%NovemberDecember2025FebruaryMarchApril
35.73%
29.13%
CRNC
BDSX

Financials

CRNC vs. BDSX - Financials Comparison

This section allows you to compare key financial metrics between Cerence Inc. and Biodesix, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items